We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.21%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$2.28B
AUM Growth
+$25.9M
(+1.1%)
Cap. Flow
-$48.9M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
56.73%
Holding
317
New
10
Increased
21
Reduced
98
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$38M |
| 2 |
Mercado Libre
MELI
|
+$16.2M |
| 3 |
GE Aerospace
GE
|
+$12.8M |
| 4 |
GE Vernova
GEV
|
+$5.35M |
| 5 |
Ares Management
ARES
|
+$4.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$38.3M |
| 2 |
Boeing
BA
|
+$22.7M |
| 3 |
Lam Research
LRCX
|
+$9.55M |
| 4 |
Apple
AAPL
|
+$9.24M |
| 5 |
Fair Isaac
FICO
|
+$6.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.87% |
| 2 | Consumer Discretionary | 13.06% |
| 3 | Healthcare | 11.97% |
| 4 | Communication Services | 10.82% |
| 5 | Industrials | 8.23% |
Similar funds
ZF
AG
NRCM
CWM
BAM
PFM
DMIC
LIP
Silvant Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Silvant Capital Management held 317 positions worth $2.28B, up 1.1% from $2.25B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Silvant Capital Management's Q3 2024 filing shows 10 new, 21 increased, 98 reduced and 14 closed positions. Its largest new stake was Ares Management: 32,755 shares worth $5.1M. The largest sale was Edwards Lifesciences, an estimated $38.3M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Silvant Capital Management's largest Q3 2024 buy was Ares Management: 32,755 shares worth $5.1M.
- Silvant Capital Management added most to Netflix in Q3 2024, an estimated $38M increase.
- Silvant Capital Management's biggest Q3 2024 reduction was Boeing, cutting an estimated $22.7M.
- Silvant Capital Management fully exited Edwards Lifesciences in Q3 2024, selling an estimated $38.3M.
- Silvant Capital Management's ten largest holdings make up 57% of its $2.28B portfolio in Q3 2024.
- Silvant Capital Management opened 10 new positions and closed 14 in Q3 2024.
- Silvant Capital Management's portfolio value rose 1.1% quarter-over-quarter to $2.28B.
Based on Silvant Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.